Cosentyx: A Treatment Option for Psoriasis and Psoriatic Arthritis - What Age is Appropriate?
Psoriasis and psoriatic arthritis are chronic autoimmune diseases that can significantly impact a person's quality of life. Cosentyx, a biologic medication, has been shown to be effective in treating these conditions. However, determining the appropriate age for Cosentyx treatment is crucial to ensure its safe and effective use.
What is Cosentyx?
Cosentyx, also known as secukinumab, is a human monoclonal antibody that targets interleukin-17A (IL-17A), a protein involved in the inflammatory process of psoriasis and psoriatic arthritis. It is administered via injection and has been approved by the FDA for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Psoriasis and Psoriatic Arthritis in Children and Adolescents
While Cosentyx has been studied in adults, its use in children and adolescents is less well-established. Psoriasis and psoriatic arthritis can occur in children and adolescents, and these conditions can have a significant impact on their quality of life.
Cosentyx in Pediatric Patients
According to the FDA, Cosentyx is not approved for use in pediatric patients under the age of 18. However, there have been studies conducted in children and adolescents with psoriasis and psoriatic arthritis.
A Study on Cosentyx in Pediatric Patients
A study published in the Journal of the American Academy of Dermatology found that Cosentyx was effective in treating moderate to severe plaque psoriasis in pediatric patients aged 6-17 years. The study included 50 patients who received Cosentyx for 52 weeks, and the results showed significant improvements in skin clearance and quality of life.
Expert Opinion
Dr. Mark Lebwohl, a dermatologist and professor at the Icahn School of Medicine at Mount Sinai, notes that "while Cosentyx has not been approved for use in pediatric patients, it has been used off-label in this population with good results." He adds that "further studies are needed to fully understand the safety and efficacy of Cosentyx in children and adolescents."
Cosentyx in Adults
In adults, Cosentyx has been shown to be effective in treating moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. A study published in the New England Journal of Medicine found that Cosentyx was superior to placebo in achieving skin clearance and improving quality of life in patients with moderate to severe plaque psoriasis.
Age-Related Considerations
When considering Cosentyx treatment, age-related factors must be taken into account. Older adults may be more susceptible to infections and other adverse effects, while younger adults may be more likely to experience skin reactions.
Cosentyx and Pregnancy
Cosentyx is a category C medication, meaning that its safety in pregnancy has not been established. Women of childbearing age should use effective contraception while taking Cosentyx, and those who become pregnant while taking the medication should discuss their options with their healthcare provider.
Key Takeaways
* Cosentyx is not approved for use in pediatric patients under the age of 18.
* While Cosentyx has been used off-label in children and adolescents, further studies are needed to fully understand its safety and efficacy in this population.
* In adults, Cosentyx has been shown to be effective in treating moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.
* Age-related factors, such as susceptibility to infections and skin reactions, must be taken into account when considering Cosentyx treatment.
* Women of childbearing age should use effective contraception while taking Cosentyx.
Frequently Asked Questions
1. Q: Is Cosentyx approved for use in pediatric patients?
A: No, Cosentyx is not approved for use in pediatric patients under the age of 18.
2. Q: Has Cosentyx been studied in children and adolescents?
A: Yes, there have been studies conducted in children and adolescents with psoriasis and psoriatic arthritis.
3. Q: What are the potential side effects of Cosentyx?
A: Common side effects of Cosentyx include injection site reactions, upper respiratory tract infections, and fatigue.
4. Q: Can Cosentyx be used during pregnancy?
A: No, the safety of Cosentyx in pregnancy has not been established, and women of childbearing age should use effective contraception while taking the medication.
5. Q: How long does Cosentyx take to work?
A: Cosentyx typically takes several weeks to start working, and it may take several months to achieve optimal results.
Sources:
1. FDA Approval Letter. (2015). Secukinumab (Cosentyx) for the treatment of moderate to severe plaque psoriasis.
2. Journal of the American Academy of Dermatology. (2018). Efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis.
3. New England Journal of Medicine. (2015). Secukinumab for the treatment of moderate to severe plaque psoriasis.
4. DrugPatentWatch.com. (2022). Secukinumab (Cosentyx) patent expiration.
5. Mount Sinai Health System. (2022). Psoriasis and psoriatic arthritis in children and adolescents.